Gene Symbol | JUNB |
Entrez ID | 3726 |
Uniprot ID | P17275 |
Description | jun B proto-oncogene |
Chromosomal Location | chr19: 12,791,496-12,793,315 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter |
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IBA |
BP |
GO:0001570 |
vasculogenesis |
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes. |
IEA |
BP |
GO:0001649 |
osteoblast differentiation |
The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone. |
IEA |
BP |
GO:0001829 |
trophectodermal cell differentiation |
The process in which a relatively unspecialized cell acquires the specialized features of a trophectoderm cell. |
IEA |
BP |
GO:0006357 |
regulation of transcription from RNA polymerase II promoter |
Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
TAS |
BP |
GO:0006366 |
transcription from RNA polymerase II promoter |
The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). |
IEA |
BP |
GO:0009314 |
response to radiation |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation. |
IBA |
BP |
GO:0009612 |
response to mechanical stimulus |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
IBA |
BP |
GO:0010941 |
regulation of cell death |
Any process that modulates the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. |
IBA |
BP |
GO:0030316 |
osteoclast differentiation |
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue. |
IEA |
BP |
GO:0032496 |
response to lipopolysaccharide |
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
IBA |
BP |
GO:0032870 |
cellular response to hormone stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus. |
IBA |
BP |
GO:0033687 |
osteoblast proliferation |
The multiplication or reproduction of osteoblasts, resulting in the expansion of an osteoblast cell population. An osteoblast is a bone-forming cell which secretes an extracellular matrix. Hydroxyapatite crystals are then deposited into the matrix to form bone. |
IEA |
BP |
GO:0034097 |
response to cytokine |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
IBA |
BP |
GO:0042127 |
regulation of cell proliferation |
Any process that modulates the frequency, rate or extent of cell proliferation. |
IBA |
BP |
GO:0042493 |
response to drug |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
IBA |
BP |
GO:0045597 |
positive regulation of cell differentiation |
Any process that activates or increases the frequency, rate or extent of cell differentiation. |
IBA |
BP |
GO:0045944 |
positive regulation of transcription from RNA polymerase II promoter |
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
IBA|TAS |
BP |
GO:0046697 |
decidualization |
The cellular and vascular changes occurring in the endometrium of the pregnant uterus just after the onset of blastocyst implantation. This process involves the proliferation and differentiation of the fibroblast-like endometrial stromal cells into large, polyploid decidual cells that eventually form the maternal component of the placenta. |
IEA |
BP |
GO:0051591 |
response to cAMP |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus. |
IBA |
BP |
GO:0051726 |
regulation of cell cycle |
Any process that modulates the rate or extent of progression through the cell cycle. |
IBA |
BP |
GO:0060136 |
embryonic process involved in female pregnancy |
A reproductive process occurring in the embryo or fetus that allows the embryo or fetus to develop within the mother. |
IEA |
BP |
GO:0060716 |
labyrinthine layer blood vessel development |
The process whose specific outcome is the progression of a blood vessel of the labyrinthine layer of the placenta over time, from its formation to the mature structure. The embryonic vessels grow through the layer to come in close contact with the maternal blood supply. |
IEA |
BP |
GO:0071277 |
cellular response to calcium ion |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
IEA |
CC |
GO:0000785 |
chromatin |
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. |
TAS |
CC |
GO:0000790 |
nuclear chromatin |
The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus. |
IBA |
CC |
GO:0005654 |
nucleoplasm |
That part of the nuclear content other than the chromosomes or the nucleolus. |
IDA|TAS |
CC |
GO:0005667 |
transcription factor complex |
A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. |
IBA |
MF |
GO:0000978 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding |
Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II. |
IBA |
MF |
GO:0000981 |
RNA polymerase II transcription factor activity, sequence-specific DNA binding |
Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
IBA |
MF |
GO:0001077 |
transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter. |
IEA |
MF |
GO:0003677 |
DNA binding |
Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
TAS |
MF |
GO:0003713 |
transcription coactivator activity |
Interacting selectively and non-covalently with a activating transcription factor and also with the basal transcription machinery in order to increase the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. |
TAS |
MF |
GO:0003714 |
transcription corepressor activity |
Interacting selectively and non-covalently with a repressing transcription factor and also with the basal transcription machinery in order to stop, prevent, or reduce the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between repressive transcription factors and the basal transcription machinery. |
TAS |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0008134 |
transcription factor binding |
Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
IBA |
Domain ID | Description |
---|---|
IPR002112 |
Transcription factor Jun |
IPR004827 |
Basic-leucine zipper domain |
IPR005643 |
Jun-like transcription factor |
IPR008917 |
Transcription factor, Skn-1-like, DNA-binding domain |
IPR029822 |
Transcription factor JunB |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04380 |
Osteoclast differentiation |
KEGG |
hsa04668 |
TNF signaling pathway |
KEGG |
WP304 |
Kit receptor signaling pathway |
WikiPathways |
WP366 |
TGF-beta Signaling Pathway |
WikiPathways |
WP3611 |
Photodynamic therapy-induced AP-1 survival signaling. |
WikiPathways |
WP2355 |
Corticotropin-releasing hormone signaling pathway |
WikiPathways |
WP2374 |
Oncostatin M Signaling Pathway |
WikiPathways |
WP2873 |
Aryl Hydrocarbon Receptor Pathway |
WikiPathways |
WP408 |
Oxidative Stress |
WikiPathways |
WP364 |
IL-6 signaling pathway |
WikiPathways |
h_GATA3pathway |
GATA3 participate in activating the Th2 cytokine genes expression |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0024121 |
Lung Neoplasms |
C0038220 |
Status Epilepticus |
C0151744 |
Myocardial Ischemia |
C0740392 |
Infarction, Middle Cerebral Artery |
Tissue | Cell Type |
---|---|
bronchus |
respiratory epithelial cells |
skeletal muscle |
myocytes |
skin |
keratinocytes |
skin |
epidermal cells |
smooth muscle |
smooth muscle cells |
soft tissue |
fibroblasts |
soft tissue |
peripheral nerve |
tonsil |
squamous epithelial cells |
urinary bladder |
urothelial cells |
vagina |
squamous epithelial cells |
Pubmed ID | Author | Year | Title |
---|---|---|---|
15308691 |
Jansen et al. |
2004 |
Abnormal Gene Expression Profiles in Human Ovaries from Polycystic Ovary Syndrome Patients |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
MAPK13 |
5603 |
O15264 |
0.00 |
SOCS2 |
8835 |
O14508 |
0.00 |
MAFG |
4097 |
O15525 |
0.49 |
MAP2 |
4133 |
P11137 |
0.56 |
TCERG1 |
10915 |
O14776 |
0.56 |
ZNF595 |
152687 |
Q8IYB9 |
0.56 |
FOSB |
2354 |
P53539 |
0.59 |
NFE2L1 |
4779 |
Q14494 |
0.62 |
NEU1 |
4758 |
Q99519 |
0.63 |
MAPK6 |
5597 |
Q16659 |
0.63 |
SET |
6418 |
Q01105 |
0.63 |
YY1 |
7528 |
P25490 |
0.63 |
TCL1A |
8115 |
P56279 |
0.63 |
ATF7 |
11016 |
P17544 |
0.63 |
NINL |
22981 |
Q9Y2I6 |
0.63 |
ATF4 |
468 |
P18848 |
0.65 |
SMURF1 |
57154 |
Q9HCE7 |
0.68 |
BCL6 |
604 |
P41182 |
0.76 |
EP300 |
2033 |
Q09472 |
0.81 |
ATF2 |
1386 |
P15336 |
0.82 |
JUNB |
3726 |
P17275 |
0.83 |
BRCA1 |
672 |
P38398 |
0.90 |
FOSL1 |
8061 |
P15407 |
0.95 |
CREB1 |
1385 |
P16220 |
0.00 |
ATF1 |
466 |
P18846 |
0.49 |
ZNF773 |
374928 |
Q6PK81 |
0.49 |
ESR1 |
2099 |
P03372 |
0.52 |
APLP2 |
334 |
Q06481 |
0.56 |
PKIA |
5569 |
P61925 |
0.56 |
UBC |
7316 |
P0CG48 |
0.56 |
USP24 |
23358 |
Q9UPU5 |
0.56 |
MAPK14 |
1432 |
Q16539 |
0.62 |
BDNF |
627 |
P23560 |
0.63 |
CREBBP |
1387 |
Q92793 |
0.63 |
HOXA7 |
3204 |
P31268 |
0.63 |
NPM1 |
4869 |
P06748 |
0.63 |
SAT1 |
6303 |
P21673 |
0.63 |
TDG |
6996 |
Q13569 |
0.65 |
JUN |
3725 |
P05412 |
0.70 |
EGR1 |
1958 |
P18146 |
0.72 |
RFWD2 |
64326 |
Q8NHY2 |
0.72 |
SMARCA4 |
6597 |
P51532 |
0.73 |
SUMO2 |
6613 |
P61956 |
0.74 |
C19orf68 |
374920 |
Q86XI8 |
0.75 |
JDP2 |
122953 |
Q8WYK2 |
0.77 |
DDIT3 |
1649 |
P35638 |
0.83 |
BATF3 |
55509 |
Q9NR55 |
0.83 |
ATF3 |
467 |
P18847 |
0.84 |
MAPK9 |
5601 |
P45984 |
0.84 |
MAPK8 |
5599 |
P45983 |
0.85 |
BATF2 |
116071 |
Q8N1L9 |
0.87 |
SMAD4 |
4089 |
Q13485 |
0.88 |
BATF |
10538 |
Q16520 |
0.88 |
SMAD3 |
4088 |
P84022 |
0.89 |
FOSL2 |
2355 |
P15408 |
0.94 |
FOS |
2353 |
P01100 |
0.97 |